Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Algorae Pharmaceuticals Ltd

1AI.AX ✗ NOT COMPLIANT ☆ Track — members

ASX · Healthcare · Biotechnology & Medical Research ·

Australia Micro Cap Analyst: N/A

Last Close

$0.01

▲ +0.00%

Market Cap $15.73M · Vol 51.41K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$15.73M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

33.33

Momentum

Beta

0.30

vs Market

52W High

$0.02

53.74% below

52W Low

$0.00

73.35% above

Volume

51.41K

Avg 632.78K

P/B

3.79

Price-to-book

ROE

N/A

Return on equity

Free Float

66.89%

Public shares

Shariah Compliance8 STANDARDS

✗ Algorae Pharmaceuticals Ltd (1AI.AX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 1AI.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-12.00%

-15.38%

-45.00%

YTD

-21.43%

+57.14%

-19.54%

-10.35%

Financials & Valuation

TTM · Annual

Total Revenue	$92.81K
Net Income	$-528,347.00
Revenue Growth (YoY)	-43.62%
Gross Margin	100.00%
Operating Margin	-1,102.77%
Net Profit Margin	-569.27%
ROE	N/A
ROA · ROIC	-55.09% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	59.82
P/B	3.79
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	2.03B

Technical Indicators

50-Day SMA	$0.01
200-Day SMA	$0.01
RSI (14)	33.33
Beta	0.30
52-Week High	$0.02
52-Week Low	$0.00

Volume Today	51.41K
Avg Daily Volume (30D)	632.78K
Relative Volume	0.08x
Volatility (10D)	74.09
Volatility (30D)	71.25
Free Float	66.89%

Analyst Consensus

N/A

Current Price $0.01

Mean Target N/A

52W Low$0.00 52W High$0.02

Current

Target

$0.00 $0.02

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001SBWDB6

ISINAU0000296022

CountryAustralia

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Algorae Pharmaceuticals Limited is an Australia-based artificial-intelligence (AI) enabled pharmaceutical development company. The Company’s proprietary AI platform, Algorae Operating System (AlgoraeOS), is an AI platform that leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. Its other drug candidates include AI-116, AI-168, NTCELL. AI-116 is a combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualized to be a potential treatment for dementia, including Alzheimer’s disease. AI-168 is a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient, which is conceptualized to be a potential treatment for cardiovascular disease, including hypertension. NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells.